Leinco Technologies offers recombinant chimeric antibodies which offer many advantages over those produced from traditional hybridoma technology.
Respiratory Syncytial Virus (RSV): Continued Research for the Most Prevalent Respiratory Virus Among Children
RSV is a significant respiratory virus in young children, & is the primary cause of hospitalisations, particularly bronchiolitis & pneumonia.
Are you including Kupffer Cells in your hepatic models?
Doubting whether to include immune cells in your model? Including Kuppfer cells allows you to better study iDILI & improve hepatocyte functionality.
New nomenclature for liver disease (NASH and NAFLD vs MASH and MASLD)
The liver diseases of nonalcoholic fatty liver disease (NAFLD) & nonalcoholic steatohepatitis (NASH) have changed names by a modified Delphi process.
Causes Of High Background In ELISA Tests and How to Solve Them
Krishgen’s scientific team has put together a list of potential causes of high background in ELISA results and some quick tips on how to prevent them.
Advancements in the understanding of m7G Modification
There is more data that highlights the significant role of m7G modification in human diseases, particularly cancer.
New Innovative Product: Human R-spondin 1: Organoid Culture
MBL have a new innovative product available: Human R-spondin 1, for use in organoid culture.
Generate bladder 2D/3D models with long-term cell line HBLAK for advanced urological research
CELLnTec provides HBLAK, which has become a more conveniently available model for urological research than primary urothelial cultures.
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development
In vivo antibody studies offer a wide range of applications. Discover the significant impact of antibody selection on your experiment.
Key Growth Factors in Organoid Culture
MBL’s FGF-Max a recombinant chimeric protein, which includes both FGF-1 and FGF-2 solves the issues of using commercially available FGF-1.